Author:
Nikitina M. A.,Bragina E. Yu.,Nazarenko M. S.,Levchuk L. A.,Ivanova S. A.,Boiko A. S.,Gomboeva D. E.,Koroleva E. S.,Alifirova V. M.
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Postuma, R. B., Berg, D., Stern, M., et al., “MDS clinical diagnostic criteria for Parkinson’s disease,” Mov. Disord., 30, No. 12, 1591–601 (2015), https://doi.org/10.1002/mds.26424.
2. Parkinson Disease (June 13, 2022), World Health Organization (Aug. 9, 2023), https://www.who.int/ru/news-room/fact-sheets/detail/parkinson-disease.
3. Aldoghachi, A. F., Tor, Y. S., Redzun, S. Z., et al., “Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among Malaysian major depressive disorder patients,” PLoS One, 14, No. 1, e0211241 (2019),https://doi.org/10.1371/journal.pone.0211241
4. Bramham, C. R. and Messaoudi, E., “BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis,” Prog. Neurobiol., 76, No. 2, 99–125 (2005), https://doi.org/10.1016/j.pneurobio.2005.06.003.
5. Gottmann, K., Mittmann, T., and Lessmann, V., “BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses,” Exp. Brain Res., 199, No. 3–4, 203–234 (2009), https://doi.org/10.1007/s00221-009-1994-z.